Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Post by OleMuleon Aug 12, 2020 9:26am
315 Views
Post# 31397015

Financials

FinancialsMore of the same bullcrap.  I do find it odd that in the MD&A it states:

"In March 2020, CVR Medical and CVR Global reached a tentative agreement for restructuring the two companies. CVR Medical is to receive all the Intellectual Property (IP) relating to Infrasonic, Subsonic and Low Frequency Ultrasound in exchange for shares of CVR Medical Stock. An independent valuation of the IP is to be done to determine the share amount. The details of the restructuring plan are being finalized at which time the agreement will be presented to the TSX-v for a pre-approval process to be followed by a special meeting of the shareholders for ratification. The Board of Directors agree unanimously that the restructuring agreement is in the best interest of the CVR Medical shareholders. As a stand-alone Medical Device Company, CVR Medical takes possession of the CSS and all future devices that may be in the pipeline."

Yet on June 8th, 2020, Paul Blunden put out a press release stating that the agreement had been cancelled and rescinded.  Which is it Paul?  

Who will do the independent valuation, the same firm that conducted the valuation on CVR GLobal?  That was a farce, what was gleamed from that egregious valuation was everything was overstated including Peter Balema's and Global's contribution which they touted at $8M/$24M respectiviely yet the CVR Global Balance stated a MUCH different picture.

Come on Blunden tell the world the "NEW" plan 
<< Previous
Bullboard Posts
Next >>